HDAC inhibitors tested in phase III trial

Nat Rev Clin Oncol. 2019 Aug;16(8):465. doi: 10.1038/s41571-019-0224-2.
No abstract available

Publication types

  • Comment

MeSH terms

  • Androstadienes
  • Breast Neoplasms*
  • Double-Blind Method
  • Histone Deacetylase Inhibitors*
  • Humans
  • Postmenopause

Substances

  • Androstadienes
  • Histone Deacetylase Inhibitors
  • exemestane